# Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures

> **NCT03565211** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 352 (actual)

## Conditions studied

- Progesterone Supplementation in Women Undergoing ART

## Interventions

- **DRUG:** Progesterone vaginal ring

## Key facts

- **NCT ID:** NCT03565211
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2019-07-29
- **Final completion:** 2019-07-29
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2020-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03565211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03565211, "Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03565211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*